Gaudium IVF & Women Health Current Share Price | Gaudium IVF & Women Health Stock Screener
GAUDIUMIVF
Healthcare Service Provider
Gaudium IVF & Women Health Current Stock Price Today
Live Share Price NSE
₹124.39
▼
-1.08 (-0.86%)
Live Share Price BSE
₹118.45
▼
-2.40 (-1.99%)
As of April 24, 2026, the live Gaudium IVF & Women Health share price (NSE: GAUDIUMIVF) is ₹124.39 on NSE and ₹118.45 on BSE, down 0.86% from the previous close, with shares trading between ₹118.25 and ₹133.00 in today's trading session, and a 52-week range of ₹70.67–₹125.47.
Analyse GAUDIUMIVF share price charts and track historical price performance.
Use the Gaudium IVF & Women Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Gaudium IVF & Women Health Market Cap
₹897.32 Cr.
GAUDIUMIVF P/E Ratio (TTM)
37.46
Gaudium IVF & Women Health P/B Ratio
6.01
EPS (TTM)
₹3.92
Dividend Yield
-
Debt to Equity
0.52
GAUDIUMIVF 52 Week High
₹125.47
Gaudium IVF & Women Health 52 Week Low
₹70.67
Operating Margin
40.00%
Profit Margin
25.81%
GAUDIUMIVF Revenue (TTM)
₹31.00
EBITDA
₹12.00
Net Income
₹8.00
Total Assets
₹193.00
Total Equity
₹152.00
Gaudium IVF & Women Health Current Share Price Chart
Track the current Gaudium IVF & Women Health share price and stock price with an interactive chart. Analyse GAUDIUMIVF price trends, trading volume, historical performance, and volatility across different timeframes — the complete Gaudium IVF & Women Health stock quote in one place.
Gaudium IVF & Women Health Company Profile - Fundamental Screener
Screen Gaudium IVF & Women Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GAUDIUMIVF shares.
Sector
Healthcare
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE0P8B01020
Gaudium IVF & Women Health Balance Sheet Screener
Screen GAUDIUMIVF balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 193 | 89 | 57 | 37 | 18 |
| Current Assets | 73 | 54 | 38 | 18 | 14 |
| Fixed Assets | 29 | 18 | 19 | 18 | 4 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 4 | 4 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 152 | 46 | 33 | 23 | 9 |
| Share Capital | 36 | 31 | 1 | 1 | 1 |
| Reserves & Surplus | 116 | 16 | 32 | 22 | 8 |
Gaudium IVF & Women Health Income Statement Screener - Profit & Revenue Analysis
Screen Gaudium IVF & Women Health income statement and profit fundamentals.
Analyze GAUDIUMIVF quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Gaudium IVF & Women Health share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Dec |
|---|---|---|---|---|---|---|
| Revenue | 31 | 27 | 18 | 32 | 25 | 14 |
| Expenses | 18 | 18 | 13 | 18 | 18 | 9 |
| EBITDA | 12 | 9 | 5 | 14 | 7 | 6 |
| Operating Profit % | 40.00% | 32.00% | 29.00% | 43.00% | 27.00% | 39.00% |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 10 | 8 | 4 | 13 | 5 | 5 |
| Tax | 2 | 2 | 1 | 3 | 1 | 1 |
| Net Profit | 8 | 7 | 3 | 9 | 4 | 3 |
| EPS | 1.34 | 1.05 | 0.51 | 1.53 | 0.59 | 0.55 |
Gaudium IVF & Women Health Cash Flow Screener - Liquidity Fundamentals
Screen GAUDIUMIVF cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 9 | 3 | 24 | -1 |
| Investing Activities | -15 | -5 | -16 | -1 |
| Financing Activities | 2 | -1 | 5 | 3 |
| Net Cash Flow | -5 | -3 | 14 | 0 |
Gaudium IVF & Women Health Shareholding Pattern Screener
See Gaudium IVF & Women Health shareholding pattern with promoter, FII, and DII holdings.
Check Gaudium IVF & Women Health promoter holding and ownership changes for GAUDIUMIVF on TickJournal.
| Item | 2026-Feb | 2026-Mar | 2026-Jun | 2025-Jan | 2025-Sept |
|---|---|---|---|---|---|
| Promoter Holding | 71.29% | 71.29% | 71.29% | 99.98% | 99.98% |
| FII Holding | 9.24% | 6.70% | 3.02% | 0.00% | 0.00% |
| DII Holding | 5.11% | 2.62% | 2.22% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.52% | 14.67% | 16.78% | 0.00% | 0.00% |
| Other Holding | 0.84% | 4.73% | 6.69% | 0.02% | 0.02% |
| Shareholder Count | 7 | 19,854 | 21,910 | 7 | 7 |
Gaudium IVF & Women Health Share Dividend Screener - Share Yield Analysis
Check Gaudium IVF & Women Health dividend history with payout and yield data.
View Gaudium IVF & Women Health dividend details including ex-dates and amounts for GAUDIUMIVF stock.
Gaudium IVF & Women Health Stock Index Membership
See which indices include Gaudium IVF & Women Health stock.
Check GAUDIUMIVF index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Gaudium IVF & Women Health Market Events Screener - Corporate Actions
Get Gaudium IVF & Women Health corporate actions including splits, bonuses, and buybacks.
Check Gaudium IVF & Women Health stock events that may affect GAUDIUMIVF share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -5.06% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 0.04% |
| 2026-03-18 | 2026-03-18 | Quarterly Result Announcement | NA | 5.06% |
Gaudium IVF & Women Health Competitors Screener - Peer Comparison
Screen GAUDIUMIVF competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 32,689 | 59.81 | 2,864 | 12.11% | 510 | 74.98 |
| Vijaya Diagnostic Centre | 15,544 | 78.36 | 814 | 16.36% | 182 | 62.44 |
| Metropolis Healthcare | 11,428 | 57.82 | 1,671 | 24.15% | 191 | 48.96 |
| Thyrocare Technologies | 10,234 | 58.69 | 846 | 20.48% | 163 | 73.77 |
| Nephrocare Health Services | 6,828 | 93.56 | 1,023 | 32.93% | 77 | 60.99 |
| Krsnaa Diagnostics | 1,852 | 18.40 | 773 | 4.05% | 106 | 64.29 |
| Suraksha Diagnostic | 1,408 | 42.79 | 310 | 21.30% | 34 | 50.18 |
| One Global Service Provider | 1,221 | 17.58 | 498 | 237.06% | 69 | 58.67 |
| 3B BlackBio DX | 1,074 | 17.28 | 142 | 27.17% | 61 | 44.93 |
| Health X Platform | 932 | -36.71 | 1,319 | 12.68% | -3 | 40.60 |
Gaudium IVF & Women Health Company Announcements - News Screener
Screen GAUDIUMIVF latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - | |
| 2026-08-15 | Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026. | - |
| 2026-07-16 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-15 | Intimation Under Regulation 30 And Para B Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At South Extension New Delhi | - |
| 2026-07-11 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-25 | Gaudium IVF And Women Health Limited Has Informed The Exchange About Corrigendum To The Financial Results Submitted For The Quarter And Year Ended March 31 2026 | - |
| 2026-06-25 | Board Meeting Outcome for Approval For Setting Up Of Gaudium Women Hospital At Lucknow Uttar Pradesh | - |
| 2026-06-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-28 | Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-28 | Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-23 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-22 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Standalone And Consolidated Financial Statements/Results Of The Company For The Quarter And Year Ended March 31 2026. | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-04-16 | Clarification On Price Movement | - |